Active Ingredient History

NOW
  • Now
Perifosine is a drug candidate being developed for a variety of cancer indications. It is an alkyl-phospholipid structurally related to miltefosine. It acts as an Akt inhibitor and a PI3K inhibitor. It was being developed by Keryx Biopharmaceuticals who have licensed it from Æterna Zentaris Inc.   Wikipedia

  • SMILES: CCCCCCCCCCCCCCCCCCOP(=O)([O-])OC1CC[N+](C)(C)CC1
  • InChIKey: SZFPYBIJACMNJV-UHFFFAOYSA-N
  • Mol. Mass: 461.67
  • ALogP: 6.99
  • ChEMBL Molecule:
More Chemistry
d 21266 | d-21266 | krx-0401 | octadecyl-(1,1-dimethyl-4-piperidylio)phosphate | perifosine

Feedback

Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

Report issue